Literature DB >> 499919

Eosinophils in the rectal mucosa. A simple method of predicting the outcome of ulcerative proctocolitis?

R V Heatley, P D James.   

Abstract

One-hundred-and-thirteen rectal biopsies and 17 total colectomy specimens from 50 patients with ulcerative proctocolitis were examined. These patients had been followed for periods up to 220 months, mean 70 months. The histological changes were compared with the clinical features of the disease. Patients with relatively benign disease which responded to treatment had significantly raised eosinophil counts in the mucosa examined, compared with patients who had aggressive disease which failed to respond to medical treatment (P less than 0.001). Tissue eosinophilia in the rectal mucosa may provide a simple method for predicting the clinical course of patients with ulcerative proctocolitis.

Entities:  

Mesh:

Year:  1979        PMID: 499919      PMCID: PMC1412652          DOI: 10.1136/gut.20.9.787

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  6 in total

1.  CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS.

Authors:  A P DICK; M J GRAYSON; R G CARPENTER; A PETRIE
Journal:  Gut       Date:  1964-10       Impact factor: 23.059

2.  PREDNISONE AS MAINTENANCE TREATMENT FOR ULCERATIVE COLITIS IN REMISSION.

Authors:  J E LENNARD-JONES; J J MISIEWICZ; A M CONNELL; J H BARON; F A JONES
Journal:  Lancet       Date:  1965-01-23       Impact factor: 79.321

3.  The prognosis of idiopathic proctitis.

Authors:  J Powell-Tuck; J K Ritchie; J E Lennard-Jones
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

4.  Treatment of ulcerative colitis with oral disodium cromoglycate. A double-blind controlled trial.

Authors:  V Mani; G Lloyd; F H Green; H Fox; L A Turnberg
Journal:  Lancet       Date:  1976-02-28       Impact factor: 79.321

5.  Histamine content of rectal mucosa in ulcerative colitis.

Authors:  V Binder; E Hvidberg
Journal:  Gut       Date:  1967-02       Impact factor: 23.059

6.  Disodium cromoglycate in the treatment of chronic proctitis.

Authors:  R V Heatley; B J Calcraft; J Rhodes; E Owen; B K Evans
Journal:  Gut       Date:  1975-07       Impact factor: 23.059

  6 in total
  19 in total

1.  Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study.

Authors:  Jeffrey S Hyams; Sonia Davis Thomas; Nathan Gotman; Yael Haberman; Rebekah Karns; Melanie Schirmer; Angela Mo; David R Mack; Brendan Boyle; Anne M Griffiths; Neal S LeLeiko; Cary G Sauer; David J Keljo; James Markowitz; Susan S Baker; Joel Rosh; Robert N Baldassano; Ashish Patel; Marian Pfefferkorn; Anthony Otley; Melvin Heyman; Joshua Noe; Maria Oliva-Hemker; Paul A Rufo; Jennifer Strople; David Ziring; Stephen L Guthery; Boris Sudel; Keith Benkov; Prateek Wali; Dedrick Moulton; Jonathan Evans; Michael D Kappelman; M Alison Marquis; Francisco A Sylvester; Margaret H Collins; Suresh Venkateswaran; Marla Dubinsky; Vin Tangpricha; Krista L Spada; Bradley Saul; Jessie Wang; Jose Serrano; Kevin Hommel; Urko M Marigorta; Greg Gibson; Ramnik J Xavier; Subra Kugathasan; Thomas Walters; Lee A Denson
Journal:  Lancet       Date:  2019-03-29       Impact factor: 79.321

2.  Expression of apoptotic epithelial cells in biopsy specimens of patients with colitis.

Authors:  Kazuko Shichijo; Takeshi Shin; Chun-Yang Wen; Toshiyuki Nakayama; Masahiro Nakashima; Alipov Gabit Kaimovich; Mutsumi Matsuyama; Ichiro Sekine
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

Review 3.  Pathological mimics of chronic inflammatory bowel disease.

Authors:  N A Shepherd
Journal:  J Clin Pathol       Date:  1991-09       Impact factor: 3.411

4.  Prognostic indicators and clinical course in proctosigmoiditis.

Authors:  L D Juby; D E Long; M F Dixon; A T Axon
Journal:  Int J Colorectal Dis       Date:  1990-12       Impact factor: 2.571

5.  Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls.

Authors:  S C Bischoff; J Grabowsky; M P Manns
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

6.  Lamina propria eosinophils and mast cells in ulcerative colitis: comparison between Asians and Caucasians.

Authors:  G F Benfield; R Bryan; J Crocker
Journal:  J Clin Pathol       Date:  1990-01       Impact factor: 3.411

7.  Mucosal Eosinophilia Is an Independent Predictor of Vedolizumab Efficacy in Inflammatory Bowel Diseases.

Authors:  Erin M Kim; Cara Randall; Renee Betancourt; Staci Keene; Amy Lilly; Mark Fowler; Evan S Dellon; Hans H Herfarth
Journal:  Inflamm Bowel Dis       Date:  2020-07-17       Impact factor: 5.325

8.  Evaluation of mucosal eosinophils in the pediatric colon.

Authors:  Licia Pensabene; Marie-Anne Brundler; Juliane M Bank; Carlo Di Lorenzo
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

9.  In vitro immunoglobulin secretion by normal human gastrointestinal mucosal tissues, and alterations in patients with inflammatory bowel disease.

Authors:  V A Danis; A D Harries; R V Heatley
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

10.  Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study.

Authors:  S K Sarin; V Malhotra; S Sen Gupta; A Karol; S K Gaur; B S Anand
Journal:  Dig Dis Sci       Date:  1987-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.